Suggestions
Cedric Bogaert
co-founder / CEO myNEO Therapeutics
Cedric Bogaert is the Co-Founder and CEO of myNEO Therapeutics, a biotechnology company focused on immunotherapy solutions. He is also a member of the company's Board of Directors. Bogaert has gained recognition for his contributions to the field, including being named to the Forbes 30 Under 30 Europe List in 2023, which highlights young leaders and innovators in various sectors, particularly for his work related to myNEO.13
Under his leadership, myNEO Therapeutics has developed a platform that specializes in neoantigen-based immunotherapies, which are tailored treatments designed to enhance the body's immune response against cancer.15 His professional background includes significant experience in data analysis and life sciences, further underscoring his expertise in the biotech industry.24
Highlights
It's always impressive to come back to the myNEO HQ after conference season and see the progress the team has made in the latest sprints. This morning I was demoed the new version of myNEO's patient report. It visualizes all tumor epitopes identified in the tumor tissue of a particular patient, ranked according to various parameters for personalized immunotherapy development. This platform fully integrates the myNEO Therapeutics technology in the back-end, which is launched automatically on temporary cloud instances as soon as the tumor data are deposited onto our servers. Fast, consistent, and highly precise in identifying novel patient targets for immunotherapy development. All while taking regulatory requirements for personalized clinical studies into account. Over the past year, we have tested this personalized neoantigen-identification reporting platform with different clinical and industrial collaborators, and this version is planned to be driving developments in the first clinical studies in the coming year. Wanted to share a sneak peak already, but more news will follow soon!
#myNEO #Immunotherapy #neoantigens #IntegratedGenomicViewer
Busy week in London filled with presentations on myNEO Therapeutics' latest developments! This morning I gave a lengthy presentation at the Immuno Oncology Summit, and we were invited to give a further shorter session later this week at Biotrinity.
Looking forward to more partnering discussions on IO/AI in the UK!
#immunooncology #myneo #IOsummit2024 #biotrinity2024
